PXD005354 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Pharmacoproteomic characterisation of human colon and rectal cancer - CRC65 Full Proteomes |
Description | Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of >10,000 proteins using mass spectrometry. Integration with proteomes of 90 CRC patients, as well as transcriptomes of 145 cell lines and 89 patients defined integrated CRC subtypes, highlighting cell lines representative of each tumour subtype. Modelling the responses of 52 CRC cell lines to 577 drugs as a function of proteome profiles enabled predicting drug sensitivity for cell lines and patients. Among many novel associations, MERTK was identified as a predictive marker for resistance towards MEK1/2 inhibitors and immunohistochemistry of 1,000 CRC tumours confirmed MERTK as a prognostic survival marker. We provide the proteomic and pharmacological data to the community to e.g. facilitate the design of innovative prospective clinical trials. |
HostingRepository | PRIDE |
AnnounceDate | 2024-10-22 |
AnnouncementXML | Submission_2024-10-22_04:34:18.951.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Martin Frejno |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | monohydroxylated residue; acetylated residue; iodoacetamide derivatized residue |
Instrument | LTQ Orbitrap Velos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2016-11-15 04:50:43 | ID requested | |
1 | 2017-10-27 03:01:46 | announced | |
2 | 2017-11-07 04:07:39 | announced | Updated publication reference for PubMed record(s): 29101300. |
3 | 2017-12-13 06:14:24 | announced | Updated project metadata. |
⏵ 4 | 2024-10-22 04:34:27 | announced | 2024-10-22: Updated project metadata. |
Publication List
Frejno M, Zenezini Chiozzi R, Wilhelm M, Koch H, Zheng R, Klaeger S, Ruprecht B, Meng C, Kramer K, Jarzab A, Heinzlmeir S, Johnstone E, Domingo E, Kerr D, Jesinghaus M, Slotta-Huspenina J, Weichert W, Knapp S, Feller SM, Kuster B, Pharmacoproteomic characterisation of human colon and rectal cancer. Mol Syst Biol, 13(11):951(2017) [pubmed] |
10.15252/msb.20177701; |
Keyword List
curator keyword: Biomedical |
submitter keyword: personalised medicine, integrated Full Proteome Subtypes,CRC65, mass spectrometry, correlation of mRNA and protein abundance, patient stratification, Consensus Molecular Subtypes, CPTAC, QUASAR2, Kinobeads |
Contact List
Bernhard Kuster |
contact affiliation | Chair of Proteomics and Bioanalytics, Technische Universität München, Germany |
contact email | kuster@tum.de |
lab head | |
Martin Frejno |
contact affiliation | TUM |
contact email | martin.frejno@tum.de |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD005354 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD005354
- Label: PRIDE project
- Name: Pharmacoproteomic characterisation of human colon and rectal cancer - CRC65 Full Proteomes